TNSN89039A1 - Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales - Google Patents

Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales

Info

Publication number
TNSN89039A1
TNSN89039A1 TNTNSN89039A TNSN89039A TNSN89039A1 TN SN89039 A1 TNSN89039 A1 TN SN89039A1 TN TNSN89039 A TNTNSN89039 A TN TNSN89039A TN SN89039 A TNSN89039 A TN SN89039A TN SN89039 A1 TNSN89039 A1 TN SN89039A1
Authority
TN
Tunisia
Prior art keywords
6alkyl
hydrogen
benzodiazepin
ones
6alkenyl
Prior art date
Application number
TNTNSN89039A
Other languages
English (en)
Inventor
Herman Margaretha Raeymaekers Alfons
Ludovicus Josephus
Van Gelder Hubertus
Joseph Kukla Michael
Joseph Breslin Henry
Adriaan Jan Janssen Paul
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of TNSN89039A1 publication Critical patent/TNSN89039A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

NOUVELLES TETRAHYDROIMIDAZO(1,4)BENZODIAZEPIN-2-ONES POSSEDANT UNE ACTIVITE ANTIVIRALE. COMPOSITIONS CONTENANT CES COMPOSES A TITRE DE PRINCIPE ACTIF ET PROCEDES DE TRAITEMENT DE SUJETS SOUFFRANT D'INFECTIONS VIRALES PAR L'ADMINISTRATION DESDITS COMPOSES
TNTNSN89039A 1988-03-18 1989-03-19 Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales TNSN89039A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888806449A GB8806449D0 (en) 1988-03-18 1988-03-18 Antiviral hexahydroimiazo(1 4)benzodiazepin-2-ones

Publications (1)

Publication Number Publication Date
TNSN89039A1 true TNSN89039A1 (fr) 1991-02-04

Family

ID=10633662

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN89039A TNSN89039A1 (fr) 1988-03-18 1989-03-19 Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales

Country Status (26)

Country Link
EP (1) EP0336466B1 (fr)
JP (1) JP2693559B2 (fr)
KR (1) KR0133073B1 (fr)
CN (1) CN1031058C (fr)
AT (1) ATE84035T1 (fr)
AU (2) AU617435B2 (fr)
BG (1) BG51251A3 (fr)
CA (1) CA1310964C (fr)
DE (1) DE68904102T2 (fr)
DK (1) DK130989A (fr)
ES (1) ES2053946T3 (fr)
FI (1) FI89800C (fr)
GB (1) GB8806449D0 (fr)
GR (1) GR3006728T3 (fr)
HU (2) HU206873B (fr)
IE (1) IE63108B1 (fr)
IL (1) IL89633A (fr)
JO (1) JO1589B1 (fr)
MY (1) MY104942A (fr)
NO (1) NO167737C (fr)
NZ (1) NZ228216A (fr)
PH (1) PH27044A (fr)
PT (1) PT90034B (fr)
SU (1) SU1748647A3 (fr)
TN (1) TNSN89039A1 (fr)
ZA (1) ZA892062B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270464A (en) * 1989-03-14 1993-12-14 Janssen Pharmaceutica N.V. Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones
IL93136A (en) * 1989-02-23 1995-01-24 Janssen Pharmaceutica Nv History of tetrahydroimidazo [1,4] benzodiazepine-2-thione, their preparation and pharmaceutical preparations containing them
NZ235137A (en) * 1989-09-13 1992-02-25 Janssen Pharmaceutica Nv Tetrahydroimidazo(1,4)benzodiazepine derivatives, preparation and pharmaceutical compositions thereof
US5164376A (en) * 1989-10-30 1992-11-17 Hoffmann-Laroche Inc. Method for treating retroviral infections with aryl-(2-pyrryl) keytone compound
EP0436245A1 (fr) * 1989-12-27 1991-07-10 Duphar International Research B.V Benzimidazol-2(1H)-ones-3,4-pontées et substituées
US5141735A (en) * 1990-06-18 1992-08-25 Hoffman-La Roche, Inc. Substituted amino-benzodiazepines having anitviral activity
NZ238664A (en) * 1990-07-06 1992-12-23 Janssen Pharmaceutica Nv Substituted tetrahydroimidazo(1,4)benzodiazepin-2-(thi)ones and pharmaceutical anti-viral compositions
GB9018601D0 (en) * 1990-08-24 1990-10-10 Fujisawa Pharmaceutical Co Tricyclic compounds
DE4036552C1 (fr) * 1990-11-16 1992-02-06 Boehringer Mannheim Gmbh, 6800 Mannheim, De
GB9109557D0 (en) 1991-05-02 1991-06-26 Wellcome Found Chemical compounds
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
WO1993023021A2 (fr) * 1992-05-13 1993-11-25 The Wellcome Foundation Limited Combinaisons therapeutiques
BRPI0815579A2 (pt) 2007-08-20 2015-02-18 Evotec Neurosciences Gmbh Tratamento de distúrbio do sono

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534257A1 (fr) * 1982-10-12 1984-04-13 Roussel Uclaf Nouveaux derives de la 6-amino 7-hydroxy 4,5,6,7-tetrahydro-imidazo/4,5,1-j-k/ /1/ benzazepin-2(1h)-one, leurs sels, application a titre de medicaments, compositions les renfermant et un intermediaire
IL93136A (en) * 1989-02-23 1995-01-24 Janssen Pharmaceutica Nv History of tetrahydroimidazo [1,4] benzodiazepine-2-thione, their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
HU911782D0 (en) 1991-12-30
HU203757B (en) 1991-09-30
FI89800C (fi) 1993-11-25
IL89633A (en) 1994-02-27
NZ228216A (en) 1991-01-29
ATE84035T1 (de) 1993-01-15
JP2693559B2 (ja) 1997-12-24
JPH01275582A (ja) 1989-11-06
IE890851L (en) 1989-09-18
HU206873B (en) 1993-01-28
NO891176D0 (no) 1989-03-17
IE63108B1 (en) 1995-03-22
NO167737B (no) 1991-08-26
DE68904102T2 (de) 1993-05-06
CN1031058C (zh) 1996-02-21
CA1310964C (fr) 1992-12-01
FI891279A0 (fi) 1989-03-17
FI89800B (fi) 1993-08-13
CN1036957A (zh) 1989-11-08
DE68904102D1 (de) 1993-02-11
NO167737C (no) 1991-12-04
AU8360291A (en) 1991-11-07
EP0336466A1 (fr) 1989-10-11
KR890014546A (ko) 1989-10-24
EP0336466B1 (fr) 1992-12-30
AU630575B2 (en) 1992-10-29
AU3131089A (en) 1989-09-21
GB8806449D0 (en) 1988-04-20
IL89633A0 (en) 1989-09-28
JO1589B1 (en) 1989-12-16
FI891279A (fi) 1989-09-19
HUT52099A (en) 1990-06-28
PH27044A (en) 1993-02-01
DK130989A (da) 1989-09-19
PT90034B (pt) 1994-05-31
PT90034A (pt) 1989-11-10
GR3006728T3 (fr) 1993-06-30
MY104942A (en) 1994-07-30
BG51251A3 (en) 1993-03-15
ZA892062B (en) 1990-11-28
AU617435B2 (en) 1991-11-28
NO891176L (no) 1989-09-19
DK130989D0 (da) 1989-03-17
KR0133073B1 (en) 1998-04-17
SU1748647A3 (ru) 1992-07-15
ES2053946T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
GR3004114T3 (fr)
IE860967L (en) Condensed oxazol-and thiazol-amines
TNSN89039A1 (fr) Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales
FI893701A0 (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
PT91613A (pt) Process for the preparation of antihypertensive 3-piperidinyl-indazole derivatives